225 related articles for article (PubMed ID: 35709853)
1. Underutilization of medical management of peripheral artery disease among patients with claudication undergoing lower extremity bypass.
Howard R; Albright J; Powell C; Osborne N; Corriere M; Laveroni E; Sukul D; Goodney P; Henke P
J Vasc Surg; 2022 Oct; 76(4):1037-1044.e2. PubMed ID: 35709853
[TBL] [Abstract][Full Text] [Related]
2. Optimal medical management before lower extremity bypass for claudication in the veteran population.
Williams CR; Jellison A; Martin L; Zhang C; Presson AP; Kraiss LW; Brooke BS
J Vasc Surg; 2019 Feb; 69(2):545-554. PubMed ID: 30108008
[TBL] [Abstract][Full Text] [Related]
3. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
[TBL] [Abstract][Full Text] [Related]
4. How Admission to a Vascular Surgery Department Improves Medical Treatment in Patients with Lower Extremity Peripheral Arterial Disease.
Thiney M; Della Schiava N; Feugier P; Lermusiaux P; Ninet J; Millon A; Long A
Ann Vasc Surg; 2017 Apr; 40():85-93. PubMed ID: 27908822
[TBL] [Abstract][Full Text] [Related]
5. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.
Armstrong EJ; Chen DC; Westin GG; Singh S; McCoach CE; Bang H; Yeo KK; Anderson D; Amsterdam EA; Laird JR
J Am Heart Assoc; 2014 Apr; 3(2):e000697. PubMed ID: 24721799
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Suboptimal Utilization of Statins and Antiplatelet Therapy in Patients Undergoing Revascularization for Symptomatic Peripheral Arterial Disease.
Meltzer AJ; Sedrakyan A; Connolly PH; Ellozy S; Schneider DB;
Ann Vasc Surg; 2018 Jan; 46():234-240. PubMed ID: 28602895
[TBL] [Abstract][Full Text] [Related]
7. Preoperative antiplatelet and statin treatment was not associated with reduced myocardial infarction after high-risk vascular operations in the Vascular Quality Initiative.
De Martino RR; Beck AW; Hoel AW; Hallett JW; Arya S; Upchurch GR; Cronenwett JL; Goodney PP;
J Vasc Surg; 2016 Jan; 63(1):182-9.e2. PubMed ID: 26409843
[TBL] [Abstract][Full Text] [Related]
8. Opioid use in patients with peripheral arterial disease undergoing lower extremity bypass.
Howard R; Albright J; Englesbe M; Osborne N; Henke P
J Vasc Surg; 2022 Mar; 75(3):998-1007. PubMed ID: 34606956
[TBL] [Abstract][Full Text] [Related]
9. Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization.
Thiney M; Della Schiava N; Ecochard R; Feugier P; Lermusiaux P; Millon A; Long A
Ann Vasc Surg; 2018 Oct; 52():138-146. PubMed ID: 29777848
[TBL] [Abstract][Full Text] [Related]
10. Prescribing of Statins After Lower Extremity Revascularization Procedures in the US.
Singh N; Ding L; Devera J; Magee GA; Garg PK
JAMA Netw Open; 2021 Dec; 4(12):e2136014. PubMed ID: 34860245
[TBL] [Abstract][Full Text] [Related]
11. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.
Soden PA; Zettervall SL; Ultee KH; Landon BE; O'Malley AJ; Goodney PP; DeMartino RR; Arya S; Schermerhorn ML;
J Vasc Surg; 2016 Dec; 64(6):1633-1644.e1. PubMed ID: 27575814
[TBL] [Abstract][Full Text] [Related]
12. Postoperative decline in ambulatory function after lower extremity bypass is associated with higher short- and long-term mortality.
Zil-E-Ali A; Patel K; Goldfarb M; Aziz F
J Vasc Surg; 2022 Jun; 75(6):2002-2012.e3. PubMed ID: 35149158
[TBL] [Abstract][Full Text] [Related]
13. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
14. Implementation of Transitional Care Planning is Associated with Reduced Readmission Rates in Patients Undergoing Lower Extremity Bypass Surgery for Peripheral Arterial Disease.
Medina D; Zil-E-Ali A; Daoud D; Brooke J; Lee Chester-Paul K; Aziz F
Ann Vasc Surg; 2022 Aug; 84():28-39. PubMed ID: 35271961
[TBL] [Abstract][Full Text] [Related]
15. Optimal medical management in patients undergoing peripheral vascular interventions for chronic limb-threatening ischemia is associated with improved outcomes.
Chang M; O'Brien-Irr MS; Shaw JF; Montross BC; Dosluoglu HH; Harris LM; Dryjski ML; Khan SZ
J Vasc Surg; 2023 Aug; 78(2):490-497. PubMed ID: 37150486
[TBL] [Abstract][Full Text] [Related]
16. Effect of adjunct femoral endarterectomy in lower extremity bypass on perioperative and 1-year outcomes.
Soden PA; Zettervall SL; Shean KE; Deery SE; Kalish JA; Healey CT; Kansal N; Schermerhorn ML;
J Vasc Surg; 2017 Mar; 65(3):711-719.e1. PubMed ID: 27633166
[TBL] [Abstract][Full Text] [Related]
17. The quality and impact of risk factor control in patients with stable claudication presenting for peripheral vascular interventions.
Ardati AK; Kaufman SR; Aronow HD; Nypaver TJ; Bove PG; Gurm HS; Grossman PM
Circ Cardiovasc Interv; 2012 Dec; 5(6):850-5. PubMed ID: 23233746
[TBL] [Abstract][Full Text] [Related]
18. Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication.
Fashandi AZ; Mehaffey JH; Hawkins RB; Kron IL; Upchurch GR; Robinson WP
J Vasc Surg; 2018 Dec; 68(6):1817-1823. PubMed ID: 30470369
[TBL] [Abstract][Full Text] [Related]
19. Identifying potentially avoidable femoral to popliteal expanded polytetrafluoroethylene bypass for claudication using cross-site blinded peer review.
Howard R; Albright J; Fleckenstein R; Forrest A; Osborne N; Corriere MA; Seth M; Laveroni E; Blebea J; Mouawad N; Henke P
J Vasc Surg; 2023 Feb; 77(2):490-496.e8. PubMed ID: 36113823
[TBL] [Abstract][Full Text] [Related]
20. Effects of statin and antiplatelet therapy noncompliance and intolerance on patient outcomes following vascular surgery.
Moore JL; McFarland GE; Novak Z; Patterson MA; Haverstock B; Passman MA; Spangler EL; Pearce BJ; Beck AW
J Vasc Surg; 2020 Apr; 71(4):1358-1369. PubMed ID: 32035776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
